Needham & Co upgrades NuVasive (Nasdaq: NUVA) from Hold to Buy. Price target $50.

Needham analyst says, "Increasing 2009 and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE